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Abstract
Differentiated embryo-chondrocyte expressed gene 1 (DEC1, also known as sharp2, stra13, or BHLHB2) is a mammalian
basic helix-loop-helix protein that is involved in many aspects of gene regulation through acting as a transcription factor.
Changes in DEC1 expression levels have been implicated in the development of cancers. Using COS-7 cell, we showed that
DEC1 can be modified by the small ubiquitin-like modifiers, SUMO1, 2 and 3. Two major SUMOylation sites (K
159 and K
279)
were identified in the C-terminal domain of DEC1. Substitution of either K
159 or K
279 with arginine reduced DEC1
SUMOylation, but substitution of both K
159 and K
279 abolished SUMOylation, and more protein appeared to be retained in
the cytoplasm compared to wild-type DEC1. The expression of DEC1 was up-regulated after serum starvation as previously
reported, but at the same time, serum starvation also led to more SUMOylation of DEC1. In MCF-7 cells SUMOylation also
stabilized DEC1 through inhibiting its ubiquitination. Moreover, SUMOylation of DEC1 promoted its repression of CLOCK/
BMAL1-mediated transcriptional activity through recruitment of histone deacetylase1. These findings suggested that
posttranslational modification of DEC1 in the form of SUMOylation may serve as a key factor that regulates the function of
DEC1 in vivo.
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Introduction
Differentiated embryo-chondrocyte expressed gene 1 (DEC1)
and it’s related protein DEC2, are members of the basic helix-
loop-helix (bHLH) family proteins that are involved in a number
of cell processes, including proliferation, apoptosis, and circadian
rhythms [1–4]. DEC1 is a 45.5-kDa protein that is expressed in a
number of human and mouse tissues, especially in skeletal muscle
[5,6]. DEC1 contains one bHLH domain in its N-terminal region
and three a-helices in its C-terminal region [7]. Its sequence shows
the highest homology with the class E members of bHLH family,
which is classified into six phylogenetic groups, A–F. However,
DEC1 lacks a WRPW motif in its C-terminus, which is essential
for the recruitment of the co-repressor Groucho[8]. There is now a
growing body of evidence suggesting that DEC1 works as a
transcriptional repressor, participating in the transcriptional
repression of peroxisome proliferator-activated receptor (PPAR)
and phosphoenolpyruvate carboxykinase (PEPCK) [9,10]. DEC1
can also act as a self-repressor by binding to E-box (CACGTG) via
a histone deacetylase 1 (HDAC1)-dependent pathway or through
interacting with components of the basal transcription machinery,
such as the transcription factor IIB (TFIIB) and the TATA binding
protein (TBP)[11–14]. In the mammalian clock system, DEC1 also
serves as a repressor for CLOCK/BMAL1 heterodimer-mediated
promoter activity, through recruitment of HDAC1 [15].
Recently, DEC1 was found to interact with nuclear receptors,
including PPAR, liver X receptor (LXR) and retinoid X receptor
(RXR) through its conserved LXXLL nuclear receptor-interacting
motif (LKDLL) in the N-terminal region, suggesting that DEC1
mediates the ligand-dependent LXR signal and functions as a
corepressor of RXR heterodimers [16,17]. In addition, DEC1
expression has been shown to be either upregulated or
downregulated in different tumors, such as breast cancer,
nonsmall-cell lung cancer, gastric cancer, during development
[18–22]. However, the important role that DEC1 plays in gene
expression and the molecular mechanisms underlying its activity in
the regulation of other transcription factors remain unclear.
SUMO (small ubiquitin-like modifier) is a small protein that is
covalently attached to its substrate at a lysine residue in the
sequence yKXE, where y is a large hydrophobic amino acid and
X represents any amino acid. SUMO is cleaved from the SUMO-
protein conjugate by SUMO-specific proteases (SENPs) [23,24].
Although, the sequence of SUMO is distantly related to ubiquitin
(18% identity), the two proteins have similar three-dimensional
structures. Interestingly, SUMO has an unstructured amino-
terminal extension containing 22 residues that it not found in
ubiquitin, and this may provide an additional signal sequence for
prospective interacting proteins [25,26]. The SUMO conjugation
pathway and the enzymes involved in the pathway have striking
similarities to those of ubiquitination. However, it has been found
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different from ubiquitin (which mainly targets its substrates for
degradation) including regulations of protein-protein interaction
and transcription, alteration of subcellular localization of proteins,
and DNA repair [27–29]. A large number of proteins have been
discovered that are subjected to SUMOylation, and many of them
are nuclear proteins with important roles in cell processes. Since
DEC1 has two consensus SUMO acceptor sites, K
159 and K
279,
both of which are contained within the yKXE sequence, we
wanted to investigate whether DEC1 can be modified by SUMO.
In this report, we showed that DEC1 can be modified by
SUMO1, 2 and 3 and demonstrated that SUMOylation occurred
at K
159 and K
279 of DEC1. Since DEC1 is associated with breast
cancer development, we further investigated how SUMOylation
may affect its activity in MCF-7 cells. We chose the core of clock
protein, CLOCK, which is involved in the regulation of breast
cancer development and is known to up-regulate DEC1
expression, and examined whether such interaction is affected by
SUMOylation of DEC1 [30,31]. Our results showed that
SUMOylation of DEC1 enhanced its repression of CLOCK/
BMAL1-mediated transcription activity through recruitment of
HDAC1 in MCF-7 cells.
Results
DEC1 is modified by SUMO1, 2 and 3
To determine whether DEC1 can be modified by SUMO,
COS-7 cells were transfected with both Flag-tagged DEC1 and
one of the three Myc-tagged SUMO expressing plasmids. Western
blot analysis of the soluble fraction of cell lysate using anti-Flag
antibody showed that DEC1 was efficiently modified by SUMO1,
2 and 3 (Figure 1A). Since the function of SUMO1 has been well
characterized compared to SUMO2 and 3, and that DEC1 was
mainly modified by SUMO1, we therefore mainly focused on the
activity of DEC1 resulting from its interaction with SUMO1 in
subsequent experiments. In addition, analysis of the SUMOylation
of DEC1 in MCF-7 cells co-transfected with Flag-tagged DEC1
and Myc-tagged SUMO1 showed that over-expressed DEC1 was
SUMOylated by SUMO1 (Figure 1B). Endogenous DEC1 in
MCF-7 cells was also SUMOylated by SUMO1 (Figure 1C), and
Figure 1. Modification of DEC1 by SUMO1, 2 and 3. (A) COS-7 cells were co-transfected with Myc-tagged SUMO1, 2 or 3 and Flag-tagged DEC1,
and then subjected to western blot with anti-Flag antibody. (B) MCF-7 cells were co-transfected with Flag-tagged DEC1 and Myc-tagged SUMO1 and
then subjected to immunoprecipitation with anti-Flag antibody followed by western blot with anti-Myc antibody. (C) Untransfected MCF-7 cells were
subjected to immunoprecipitation with anti-DEC1 antibody or anti-IgG antibody followed by western blot using anti-SUMO1 antibody. (D) MCF-7cells
were cultured in the presence of 10% serum for 24 h. The medium was then replaced with fresh medium containing either 10% or 0.8% serum and
further incubated for 12 h, and the cells were finally subjected to western blot with anti-DEC1 antibody.
doi:10.1371/journal.pone.0023046.g001
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(Figure 1D). This result indicated that serum may regulate the
SUMOylation of DEC1.
DeSUMOylation of DEC1-SUMO conjugate is mediated by
SENP1
SUMOylation is a reversible process that is catalyzed by
SUMO-specific proteases that cleave the isopeptide bond between
SUMO and the target lysine residue. Three SUMO-specific
proteases have been found in the nucleus, including SENP1,
SENP2 and SENP3. In order to determine which SENP would
affect the activity of DEC1, COS-7 cells were co-transfected with
3xE-box-luc, Flag-SENP1, SENP2 or SENP3 with HA-tagged
DEC1 and the level of reporter activity in these cells was
compared with that of COS-7 cells transfected with 3xE-box-luc
only. The level of reporter gene activity of COS-7 cells co-
transfected with 3xE-box-luc, DEC1 and SENP1 was almost
three-fold that of COS-7 transfected with DEC1 only, but was
almost similar to that of COS-7 cells transformed with only 3xE-
box-luc (Figure 2A). COS-7 cells transfected with 3xE-box-luc and
with or without SENP1 had similar levels of reporter gene activity,
indicating that SENP1 by itself, did not influence the level of
reporter activity (Data not shown). Compared to cells transfected
with 3xE-box-luc and DEC1 only, moderate increases in reporter
gene activity were also observed when the cells were co-transfected
with 3xE-box-luc, DEC1 and either the SENP1 mutant R630L/
K631M (which had lost its catalytic activity) or SENP2, while cells
transfected with 3xE-box-luc and SENP3 showed no change in
reporter gene activity. In addition, the effect of SENP1 on 3xE-
box-luc activity was dose-dependent (Figure 2B). In all cases the
expressions of HA-DEC1 and Flag-SENP1 were confirmed by
Western blot (Figure 2C). This indicated that only SENP1 could
affect the activity of DEC1 through deSUMOylation, and that
SUMOylation of DEC1 significantly reduced the level of reporter
gene activity.
K159 and K279 are primary sites for the SUMOylation of
DEC1
Analysis of the human DEC1 amino-acid sequence revealed two
conserved SUMO conjugation sites, AK
159HE and IK
279QE, in
Figure 2. Sensitivity of DEC1 SUMOylation to SENP1. (A) COS-7 cells were transfected with HA-tagged DEC1 together with 3xE-box-luc
reporter and either Flag-tagged SENP1, SENP1 mutant (mu), SENP2 or SENP3. Cells were then collected and subjected to luciferase activity assay. (B)
COS-7 cells were transfected as in (A) but with increasing amounts of Flag-SENP1 or SENP1 mutant. (C) COS-7 cells transfected as in (B) were
subjected to western blot with anti-Flag or anti-HA antibody. **, p,0.01
doi:10.1371/journal.pone.0023046.g002
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putative SUMOylation sites are conserved in different species,
such as human, rat, zebra fish and mice. To test whether K
159 and
K
279 are required for the SUMOylation of DEC1, COS-7 cells
were co-transfected with either HA-tagged wild-type or mutant
DEC1 along with SUMO1. Changing either K
159 or K
279 to
arginine resulted in reduced sumoylation of DEC1, while changing
both K
159 and K
279 to arginine led to further loss in SUMOylation
of DEC1 (Figure 3B). The mutants K
159R and K
279R exhibited
42% and 54% reduction in SUMOylation, respectively, relative to
wild-type DEC1, and while the band displayed by the double
mutant 2K/2R could well be background signal, the band
displayed by wild-type DEC1 in the absence of Myc-SUMO1
could have derived from endogenous SUMO (Figure 3B). This
indicated that both K
159 and K
279 of DEC1 can be SUMOylated
and substitution of either residue with arginine would result in
significant reduction in SUMOylation. However, since SUMOy-
lation was only abolished in the case of the double mutant 2K/2R,
all subsequent experiments whereby comparison between wild
type and mutant was made, only the double mutant was used. To
prove that the high molecular weight band detected by western
blot that corresponded to DEC1-SUMO was indeed SUMOylated
DEC1, COS-7 cells were co-transfected with DEC1, SUMO1 and
either SENP1 or its mutant. As expected, the level of SUMOylated
DEC1 was also reduced to that of background level when the cells
were co-transfected with SUMO1, wild-type DEC1and SENP1,
but not its inactive mutant (SENP1 mu) (Figure 3C), thus further
confirming the SUMOylation event of DEC1. Almost no
SUMOylation of DEC1 was observed in the absence of over-
expressed SUMO1 (Figure 3C).
Effect of SUMOylation on nucleolar distribution of DEC1
and of serum starvation on DEC1 expression
DEC1 is predominantly localized in the nucleus, but can also be
found in the cytoplasm. SUMOylation is known to affect the
subcellular localization of a protein [32,33]. To test whether
SUMOylation influence the nucleolar translocation of DEC1,
MCF-7 cells were transfected with HA-tagged wild-type DEC1 or
its mutant 2K/2R and then subjected to nucleo-cytoplasmic
separation. The mutant showed a reduced level of nucleolar
protein compared to wild-type DEC1, and though the difference
was not so prominent as seen from the blot, quantitative analysis of
individual bands showed a reduction of at least 40%, while a slight
increase of about 20% in cytoplasmic DEC1 was also obvious
(Figure 4A). The increase in cytoplasmic level of DEC1 was
somewhat much less than the corresponding reduction in
nucleolar level in the case of the mutant. This may probably be
due to loss of mutant protein via proteolysis brought about by
enhanced protein instability. The lack of effect that SUMOylation
had on the nucleolar level of DEC1 was also consistent with result
obtained from immunofluorescence staining of the cells
(Figure 4B). Previous study has reported that the level of DEC1
Figure 3. Identification of SUMOylation sites in DEC1. (A) Putative SUMOylation sites of DEC1. (B) COS-7 cells were transfected with HA-tagged
wild-type DEC1 or its mutants K159R, K279R or K159R/K279R (2K/2R) and Myc-tagged SUMO1, and then subjected to western blot with anti-HA
antibody. (C) COS-7 cells were transfected with HA-tagged wild-type DEC1 or its mutant K159R/K279R (2K/2R) with or without Flag-tagged SENP1 or
SENP1 mutant (mu) and then subjected to western blot with anti-HA antibody. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0023046.g003
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determine whether serum starvation can also affect the SUMOy-
lation of DEC1, MCF-7 cells were transiently transfected with
wild-type DEC1 and subjected to serum starvation for four
different time periods. The result showed that the level of DEC1
protein was upregulated after 6 h of serum starvation, while no
increase in the level of SUMOylated DEC1 was detected until
after 12 h (Figure 4C), in which about 30% increase in
SUMOylated DEC1 was observed, while the level of total
DEC1 was more than two-fold compared to zero time. Prolonging
the serum starvation time to 24 h led to further significant
increases in both the levels of SUMO-DEC1 and total DEC1,
becoming almost two-fold and three-fold, respectively, of those at
zero time. SUMOylation of DEC1 was therefore sensitive to
serum starvation and such sensitivity was dependent on time. In
contrast, the mutant showed no increase in either the level of total
protein or its corresponding SUMO-conjugate, while a slight drop
in the level of total protein was obvious with increases in serum
starvation time (Figure 4D).
SUMOylation of DEC1 causes repression of CLOCK/
BMAL1 activity
Previous studies have shown that DEC1 acts as a repressor that
suppresses CLOCK/BMAL1-mediated activation through bind-
ing to E-box [34]. Moreover, SUMOylation is often associated
with transcriptional regulation [28,29]. To examine the impact
that SUMOylation of DEC1 has on its repression of CLOCK/
BMAL1-mediated transcriptional activity, MCF-7 cells were
transiently transfected with a luciferase reporter driven by 3xE-
box enhancer elements, and together with Flag-tagged CLOCK,
BMAL1 and HA-tagged wild-type DEC1 or its mutant 2K/2R.
Luciferase activity assays showed that the extent of repression
exerted by the mutant on CLOCK/BMAL1-mediated transcrip-
tional activity was reduced compared to that exerted by wild-type
Figure 4. Effect of SUMOylation on nucleolar distribution of DEC1 and sensitivity of DEC1 SUMOylation to serum starvation. (A)
MCF-7 cells were transfected with HA-tagged wild-type or mutant (mu) DEC1. Cytosolic and nuclear fractions were subjected to western blot using
anti-HA antibody. Fibrillarin and b-actin were measured to monitor the efficiency of nuclear and cytosolic preparations, respectively. The graph shows
the intensities of DEC1 bands in the cytosol and nucleus. (B) MCF-7 cells were stained with mouse anti-HA antibody (green) and then counterstained
with DAPI (blue) for nucleus detection. MCF-7 cells were transfected with Flag-tagged wild-type DEC1 (C) or HA-tagged DEC1mutant 2K/2R (D) and
grown in the presence of 10% FBS before were transferred to a medium containing 0.1% FBS. Cells were collected at the indicated times and
subjected to western blot with the corresponding antibody. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0023046.g004
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dosage, but was somewhat increased with increasing dosage of the
mutant gene (Figure 5B). This was rather unexpected, but it was
repeatedly demonstrated. The expressions of CLOCK and DEC1
were also confirmed by western blot (Figure 5C). Thus
SUMOylation of DEC1 was important for its repression of
CLOCK/BMAL1 mediated activation in MCF-7 cells.
Repression of DEC1 activity is known to associate with HDAC1
[14]. In order to examine whether SUMOylation would influence
the interaction between DEC1 and HDAC1 in the repression of
CLOCK/BMAL1-mediated transcriptional activity, MCF-7 cells
were transiently transfected with Myc-HDAC1 plus either HA-
tagged wild-type or mutant DEC1. The amount of HDAC1 co-
precipitated with wild-type DEC1 was about three-fold that co-
precipitated with the mutant (Figure 5D), meaning that SUMOy-
lation of DEC1 was important for recruiting HDAC1, which is an
essential component for the repression of CLOCK/BMAL1-
mediated transcription activity in MCF-7 cells.
SUMOylation stabilizes DEC1 protein through inhibition
of DEC1 ubiquitination
The effect of SUMOylation on protein stability was examined
by transfecting MCF-7 cells with HA-tagged wild-type or mutant
DEC1, followed by treatment of the cells with the protein
translation inhibitor cycloheximide (CHX) for five different time
periods. The half-life of wild-type DEC1 was between 12 and
24 h, with about 30% of protein remaining at 24 h, whereas the
half life of DEC1 mutant 2K/2R was less than 12 h, with only
about 5% remaining at 24 h (Figure 6A). This clearly showed that
SUMOylation significantly stabilized DEC1 and increased its
half-life.
Degradation of DEC1 via the 26 S proteasome pathway
requires the covalent attachment of multiple ubiquitin molecules
to DEC1. Thus one way in which degradation of DEC1 can be
prevented is through inhibiting its ubiquitination. To investigate
whether the increased stability of DEC1 resulted from its
SUMOylation was a result of suppression of its ubiquitination,
Figure 5. Effect of DEC1 SUMOylation on the repression of CLOCK/BMAL1 activity. (A) MCF-7 cells were transfected with HA-tagged wild-
type DEC1 or its mutant 2K/2R with 3xE-box-luciferase reporter and Flag-tagged CLOCK/BMAL1 and luciferase activity was determined. (B) MCF-7
cells were transfected as in (A) but with increasing concentrations of wild-type DEC1 or 2K/2R and luciferase activity was then determined. (C)
Expressions of CLOCK and DEC1 in cells from (B) were detected by western blot with anti-Flag or anti-HA antibody. (D) MCF-7 cells were transfected
with HA-tagged wild-type DEC1 or 2K/2R together with Myc-tagged HDAC1. Cell lysate was subjected to IP with anti-HA antibody followed by
western blot with anti-Myc antibody. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0023046.g005
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2R and Myc-tagged ubiquitin and the level of DEC1 ubiquitina-
tion was compared to that of MCF-7 cells transfected with HA-
tagged wild-type DEC1 and Myc-tagged ubiquitin (Figure 6B).
Ubiquitination of wild-type DEC1 was reduced compared to the
mutant, indicating that SUMOylation of DEC1 inhibited its
ubiquitination.
Discussion
In this report, we demonstrated that the bHLH protein DEC1
can be modified by SUMO1, 2 and 3, which manifested as
multiple bands of high molecular weight as seen in SDS-PAGE.
These bands were consistent with the presence of multiple
SUMOylation sites in DEC1. Previous reports have proposed
that many proteins such p53, p68, CTCF and AIB1 are efficiently
modified by SUMOs at a lysine residue within the sequence
yKXE [35–38]. On the basis of this finding, we identified two
major SUMOylation sites, K
159 and K
279, in the C-terminus of
DEC1. Both sites, which conform to the consensus sequence of
yKXE, can be modified by SUMO, with K
279 displaying a larger
effect, since the K279R mutant showed lesser SUMOylation
compared to K159R mutant, although either mutant still retained
more than 40% of SUMOylation (relative to wild type) compared
to the double mutant. Furthermore, SUMOylation of DEC1 at
K
159 and K
279 could be reversed by SENP1.
SUMOylation has been shown to regulate the subcellular
localization, stability, transcriptional activity and protein-protein
interaction of transcription factors [39,40]. DEC1 is synthesized in
the cytoplasm but is then transported into the nucleus where it
functions as a transcription factor. DEC1 is transported into the
nucleus via the nuclear localization signal-dependent pathway,
which traffics a protein into the nucleus via its nuclear localization
signal (NLS). NLS binds to a membrane heterodimeric receptor
consisting of imporin-a and importin-b subunits, and mediates the
subsequent passage of the protein into the nucleus [41]. Computer
prediction revealed the presence of a basic NLS at the C-terminus
(around residue 286) of DEC1, and replacing K
159 and K
279 of
DEC1 with arginine somewhat reduced its passage into the
nucleus (Figure 4A). The attachment of SUMO to DEC1 may
increase the activity of DEC1 NLS, and therefore, enhancing its
transportation into the nucleus. This could be an important way to
facilitate the function of DEC1 (as a transcription factor).
Hypoxia and the absence of serum are two favorable conditions
for tumor cell growth. Response to hypoxia is mediated by the
hypoxia-inducible factor 1a (HIF-1a), which is known to regulate
the functions of some tumor-associated proteins, such as vascular
endothelial growth factor (VEGF), transferrin, and DEC1
[20,22,42]. However, the mechanism pertaining to how tumor
cells are able to adapt to a serum free condition in vivo (analogous
to serum starvation condition in cell culture) at the molecular level
is not clear. We showed here that the expression of DEC1 and its
SUMOylation were both up-regulated after serum starvation,
indicating that the stress of serum starvation may influence the
activity of DEC1 through SUMOylation. Since a high level of
DEC1 expression has been found in many tumors, we concluded
that serum starvation may probably affect the expression and post-
translational modification of some tumor-associated proteins in
addition to DEC1, leading to tumor proliferation.
As a clock protein, DEC1 is involved in the feed-forward
regulation of circadian rhythm. In addition to CLOCK/BMAL1,
the circadian clock feedback loop in mammals includes some other
clock proteins such as PER, CRY, REV-ERBa and DEC proteins
[43,44]. In this regulatory system, the CLOCK/BMAL1 heterodi-
mer up-regulates other clock genes through direct interaction with
the clock elements, including E-box, D-box and ROR/REV-ERB
Figure 6. Inhibition of DEC1 ubiquitination by SUMOylation. (A) MCF-7 cells were transfected with HA-tagged wild-type DEC1 or its mutant
2K/2R and treated with CHX at the indicated time periods. Cell lysate was subjected to western blot with anti-HA antibody. (B) MCF-7 cells were
transfected with HA-tagged wild-type DEC1 or 2K/2R together with Myc-tagged ubiquitin. Cell lysate was subjected to IP with anti-HA antibody
followed by western blot with anti-Myc antibody. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0023046.g006
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repressors of CLOCK/BMAL1-induced transcription by com-
peting with the clock elements for binding to CLOCK or BMAL1
[15,45–48]. Our result showed that SUMOylation of DEC1 led
to enhanced repression of CLOCK/BMAL1-mediated transcrip-
tional activity, probably through stronger binding between DEC1
and HDAC1. Binding of DEC1 to HDAC1 may be less stable in
the absence of SUMOylation, therefore accounting for a much
weaker, but still noticeable repression (,40%) of CLOCK/
BMAL1-mediated transcriptional activity observed in MCF-7
cells transfected with the DEC1 double mutant in which both
SUMOylation sites had been abolished (2K/2R, in Figure 5A). In
this experiment, the cells were not co-transfected with SUMO1,
so the status of DEC1 SUMOylation totally relied on endogenous
SUMO activity, and since the DEC1 double mutant 2K/2R
could not be SUMOylated, over-expression of this mutant
without co-expression of SUMO still justified the conclusion
drawn here stating the SUMOylation of DEC1 as part of a
regulatory event that governs its interaction with other proteins,
such as the transcription factors CLOCK/BMAL1 and the co-
repressor HDAC1. The activity of DEC1 may also be regulated
by other posttranslational modifications. Nevertheless, our result
did suggest that posttranslational modification of DEC1 in the
form of SUMOylation may be important, at least, for the
regulation of circadian rhythm.
Ubiquitin-dependent proteolysis plays an important role in
many basic cellular functions through regulating different cell
regulators, such as tumor regulators, transcriptional factors and
cell surface receptors [49,50]. DEC1 is also targeted by ubiquitin
[51]. As SUMOylation and ubiquitination are both lysine-targeted
modifications, the antagonistic relationship between SUMOyla-
tion and ubiquitination may play an important role in regulating
DEC1 activity. Interestingly, we found that SUMOylation
stabilized DEC1 through inhibiting its ubiquitination, and
therefore regulating its activity through enhancing the stability of
DEC1. Increase in the stability of DEC1 by SUMOylation was
also evident as seen with a drop in the level of nucleolar DEC1
protein with no corresponding increase in its cytoplasmic level
(Figure 4A), as well as slight decrease in the level of total DEC1
protein under serum starvation in the case of the DEC1 mutant
(Figure 4D).
DEC1 may be considered as a cancer-associated protein, and
this is highlighted by its homology with the bHLH domains of
hairy protein, which is associated with cell activation and stress in
many tissues. However, the molecular mechanisms through which
DEC1 may contribute to cancer remain unclear, although its
expression has been upregulated in a number of cancers. As
posttranslational modifications of proteins are known to play
important roles in many cell processes, we speculated that
SUMOylation may be one of the mechanisms by which the
activity of DEC1 protein is regulated. We showed here that
SUMOylation of DEC1 can alter its stability (through reducing its
susceptibility to ubiquitination) and enhance its repression of
CLOCK/BMAL1 mediated transcriptional activity. However, it is
worth noting that other posttranslational modifications of DEC1,
such as phosphorylation, acetylation, and methylation have not
been well studied, so further studies of the relevance of these
posttranslational modifications and their roles in the functions of
DEC1 are vital for increasing our understanding of the mechanism
by which the activity of DEC1 is regulated, as well as the
mechanism by which DEC1 coordinates its activity with other
accessory proteins in the regulation of cell processes. Finally, the
effect of SUMOlyation on DEC1 target genes will also need to be
addressed in order to gain more depth into the importance that it
has on DEC1 function, and we are already in the process of
carrying out this further investigation.
Materials and Methods
Plasmids and antibodies
The Flag-DEC1 construct containing human DEC1 was
obtained from Dr K. Tanimoto (Hiroshima University, Japan).
Myc-tagged SUMO1, SUMO2 and SUMO3 plasmids were
kindly provided by Dr Paul D. Sadowaki (University of Toronto,
Canada). The luciferase reporter plasmid containing three
clustered E-box elements (CACGTG) cloned into HSV-TK, and
the plasmid containing HA-tagged DEC1 were a generous gift
from Dr Moritz J. Rossner (Max-Planck-Institute of experimental
medicine, Germany). HA-tagged DEC1 mutants (K159R, K279R
and K159R/K279R (2K/2R)) were generated using site-directed
mutagenesis according to the manufacturer’s instructions (Strata-
gene, La Jolla, CA). Antibody against Flag, Myc and HA
(mouse monoclonal and rabbit polyclonal), anti-mouse and anti-
rabbit secondary antibodies were purchased from Santa Cruz
Biotechnology.
Cell culture and transfection
COS-7 and MCF-7 cells had been used in our previous
study[38]. They were maintained in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) supplemented with 10% fetal
bovine serum at 37uC in presence of 5% CO2. The cells were
transfected using Lipofectamine
TM 2000 (Invitrogen) or Vigofect
(Vigorous) according to the manufacturer’s instructions.
Immunoprecipitation and western blotting
Cells were seeded at 2610
5 per 35-mm dish and cultured for
24 h. The cells were then transfected with 1.5 mg of Flag-tagged
wild-type DEC1, HA-tagged wild-type or mutant DEC1 (K159R/
K279R) and 2.5 mg of Myc-tagged SUMO1, SUMO2 or
SUMO3. After 24 h, cells were lysed in 200 ml buffer containing
50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% SDS, 1% NP-40
and 0.5% sodium deoxycholate and centrifuged at 100006g/4uC
for 10 min. The supernatant was incubated with 2 mg of anti-HA
monoclonal antibody for 4 h and then with protein A-Sepharose
4B (Amersham Biosciences) for 12 h at 4uC, followed by
centrifugation at 50006g/4uC for 10 min. The pellet was washed
twice with wash buffer I (50 mM Tris-HCl, pH 7.5, 500 mM
Sodium chloride, 0.1% Nonidet P40, 0.05% Sodium deoxycho-
late) and once with wash buffer II (50 mM Tris-HCl, pH 7.5,
0.1% Nonidet P40, 0.05% Sodium deoxycholate), and then
subjected to SDS-PAGE in 10% gel. Protein bands in the gel were
transferred to PVDF membrane and subjected to western blot
analysis using the appropriate specific antibody. Immunoblot data
were quantified by scanning the appropriate bands of interest and
plotted as relative density of gray scale.
Immunofluorescence staining
MCF-7 cells were cultured for overnight on cover slips
immersed in DMEM medium supplemented with 10% fetal
bovine serum. The cells were then transfected with HA-tagged
wide-type or mutant (K159R/K279R) DEC1. Twenty four hours
after transfection the cells were washed three times with PBS, fixed
in 1% paraformaldehyde for 15 min at room temperature,
permeabilized with methanol for 40 min at 220uC and blocked
with 0.8% BSA for 1 h at 4uC. The cells were then incubated with
mouse anti-HA monoclonal antibody and examined according to
the manufacturer’s instructions.
Regulation of DEC1 Activity by SUMOylation
PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23046Luciferase reporter assay
Cells were seeded at 1610
5 per well in a 24-well dish and
cultured for 24 h before being transfected with appropriate
plasmid constructs. Twenty four hours after transfection, the cells
were harvested and Luc reporter assay was performed in
accordance with the manufacturer’s instructions (Promega, USA).
Statistical Analysis
All statistical analyses of data were preformed with ANOVA
with LSD method. Data are given as means 6SDs, and
significance was considered at either P value ,0.05 or 0.01 level.
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